CLICK-WRAP LICENSE AGREEMENT

Last updated: 7/02/2022

PLEASE READ THIS CLICK-WRAP LICENSE AGREEMENT CAREFULLY! IT CONTAINS VERY IMPORTANT INFORMATION ABOUT YOUR RIGHTS AND OBLIGATIONS, AS WELL AS LIMITATIONS AND EXCLUSIONS THAT MAY APPLY TO YOU. BY SELECTING THE BOX LABELED “I agree to the Terms and Conditions” AND CLICKING ON THE “Ok” BUTTON, YOU ARE AGREEING TO BE LEGALLY BOUND BY AND ARE BECOMING A PARTY TO THIS AGREEMENT. IF YOU ARE ENTERING INTO THIS AGREEMENT WITHIN THE SCOPE OF YOUR EMPLOYMENT, THEN THE TERM “LICENSEE” INCLUDES YOUR EMPLOYER AND YOU WARRANT AND REPRESENT TO MVHS THAT YOU ARE AUTHORIZED TO ACCEPT THIS AGREEMENT ON SUCH EMPLOYER’S BEHALF. IF YOU DO NOT AGREE TO ALL OF THE TERMS AND CONDITIONS OF THIS AGREEMENT, DO NOT SELECT THE BOX LABELED “I agree to the Terms and Conditions” AND CONTACT YOUR GLYCOCHECK SYSTEM PROVIDER.

This Click-Wrap License Agreement (this “Agreement”) is made between:

you, both as an individual and as an authorized user of and agent for your affiliated business, if any (each and collectively the “Licensee”), and

Microvascular Health Solutions LLC, a company organized and subsisting under the laws of Delaware, United States (“MVHS”), with principal offices located at 175 West Canyon Crest Suite 306, Alpine, Utah 84004, U.S.A., (MVHS and Licensee is each a “Party” and collectively are the “Parties”),

and is effective as of the first time Licensee selects the box labeled “I agree to the Terms and Conditions” and clicks “Ok” (the “Effective Date”) and is reaffirmed by Licensee each subsequent time Licensee selects the box labeled “I agree to the Terms and Conditions” and clicks “Ok.”

By providing the GlycoCheck System to Licensee, whether directly or through a Distributor, MVHS agrees to be legally bound by the terms and conditions of this Agreement.

RECITALS

WHEREAS, MVHS is the developer and/or distributor of a proprietary system used to measure the Glycocalyx layer and microvascular function (the “GlycoCheck System”);

WHEREAS, Licensee wishes to obtain from MVHS and MVHS wishes to grant and provide to Licensee a license to use the GlycoCheck System;

NOW, THEREFORE, in consideration of these promises and of the mutual covenants and conditions in this Agreement and other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

  1. LICENSE TO GLYCOCHECK SYSTEM
    • 1.1 MVHS agrees to provide the GlycoCheck System, with the Software Product installed on the System Hardware, to Licensee, through Distributor, if any. Licensee shall own the System Hardware and shall obtain a license to the GlycoCheck System and the Software Product as set forth herein.
    • 1.2 Subject to the terms and conditions of this Agreement, including the restrictions and license exclusions set forth elsewhere in this Agreement, MVHS hereby grants to Licensee, and Licensee hereby accepts a non-exclusive, non-transferable, limited license (without the right to grant sub-licenses) to use the GlycoCheck System for the purpose of measuring the Glycocalyx layer and microvascular function of patients for the purpose of advising such patients with respect to their personal health and wellness.
    • 1.3 Licensee shall have no right to sublicense, loan, sell, or otherwise transfer the GlycoCheck System or the Software Product, to any third party without the prior written approval of MVHS.
    • 1.4 MVHS retains all rights not expressly granted to Licensee hereunder. No right or license to Licensee shall be implied by or inferred from this Agreement except as expressly provided herein.
  2. LICENSEE’S GENERAL COVENANTS
    • 2.1 Licensee warrants that each Authorized User that uses the Glycocheck System has completed MVHS’s training modules for the Glycocheck System and is certified by MVHS to operate the Glycocheck System.
    • 2.2 Licensee warrants that each Authorized User that reports information obtained through use of the Glycocheck System to patients concerning such patient’s Glycocalyx layer and/or microvascular function has completed MVHS’s training modules for the Glycocheck System and is certified by MVHS to report information concerning a patient’s Glycocalyx layer and/or microvascular function obtained through use of the Glycocheck System.
    • 2.3 Licensee warrants that Licensee is aware of and complies with the current requirements of the Health Insurance Portability and Accountability Act.
    • 2.4 Subject to the terms and conditions of this Agreement, Licensee agrees that it will use the Software Product and GlycoCheck System only for the purpose of measuring the Glycocalyx layer and microvascular function of patients for the purpose of advising such patients with respect to their personal health and wellness. The GlycoCheck System is not to be used to diagnose or to treat any disease.
    • 2.5 Licensee shall not copy, reverse engineer, decompile, recompile, disassemble, or otherwise derive the underlying structure, information or ideas embodied in the Software Product. Licensee agrees such activities constitute a material breach of this Agreement, and are violations of MVHS’s Intellectual Property Rights, causing irreparable injury to MVHS which cannot be remedied by monetary damages alone, and which therefore entitle MVHS to injunctive relief.
    • 2.6 Licensee shall not modify or remove any components of the System Hardware in any manner. Licensee shall not install, attempt to install, nor cause to be installed, any software product on the System Hardware without prior written authorization from MVHS. Licensee agrees such activities constitute a material breach of this Agreement. Any violations of this Section 2.6 shall void any and all warranties, both express and any warranty implied under the law, on the System Hardware, Software Product, and Glycocheck System.
    • 2.7 Licensee shall not use the System Hardware, Software Product, or GlycoCheck System to develop, substantiate the performance of, or assist others to develop, or substantiate the performance of any dietary supplement or medical food that is intended to support, maintain, repair or treat the Glycocalyx layer or microvascular function.
    • 2.8 Licensee agrees that for the term of this Agreement, including the Initial Term and any subsequent Renewal Term, and for a period of one (1) year thereafter, Licensee shall not develop or manufacture, or assist others in the development or manufacture, any dietary supplement or medical food that is intended to support, maintain, repair or treat the Glycocalyx layer or microvascular function.
    • 2.9 Licensee shall be solely responsible for its and its Authorized Users’ use of the GlycoCheck System and reporting to patients of information concerning such patient’s Glycocalyx layer and/or microvascular function obtained using the Glycocalyx System, and shall ensure that Licensee and all Authorized Users abide by and comply with this Agreement in connection with their use of the GlycoCheck System and reporting of information obtained by the Glycocalyx System. Licensee shall be responsible to MVHS and any third party for any acts or omissions of Authorized Users, including, without limitation, failure of any Authorized User to comply with the terms of this Agreement. MVHS shall have the right to require Licensee to restrict or deny access to the GlycoCheck System and/or information concerning patients’ Glycocalyx layer and/or microvascular function obtained by the GlycoCheck System by any Authorized User who is not in compliance with this Agreement.
    • 2.10 Licensee acknowledges that the GlycoCheck System creates copies of the analyses performed by the GlycoCheck System and securely stores such copies in storage either on the System Hardware and/or in a cloud-based environment.
  3. CONSIDERATION
    • 3.1 In consideration of the license granted herein, Licensee shall pay to MVHS a license fee of $75 for each patient analysis performed using the GlycoCheck System (the “License Fee”). MVHS may change the License Fee from time to time upon thirty days’ written notice to Licensee.
  4. TERM AND TERMINATION
    • 4.1 This Agreement shall come into effect on the Effective Date and remain in effect for one (1) year, unless otherwise terminated pursuant to this Agreement (the “Initial Term”).
    • 4.2 At the end of the Initial Term, or any Renewal Term subsequent to the Initial Term, this Agreement will automatically renew for one (1) year (a “Renewal Term”). Each Renewal Term shall be subject to the terms and conditions of this Agreement.
    • 4.3 MVHS may terminate this Agreement at any time without prior notice and without any liability of MVHS to any party as a consequence thereof, upon the occurrence of any of the following: (i) Licensee has breached any material obligation which must be performed pursuant to this Agreement and such breach has not been cured within 30 days after notice from MVHS of the same, including, without limitation, failure to make any payment when due; (ii) Licensee has violated any applicable law or regulation in connection with its use of the GlycoCheck System, or (iii) Licensee becomes bankrupt or insolvent.
    • 4.4 Licensee may terminate this Agreement at any time, without any liability of Licensee to MVHS as a consequence thereof (other than charges accrued prior to termination), upon 30 day’s written notice of termination from Licensee.
    • 4.5 Upon termination of this Agreement by Licensee or MVHS, all license(s) granted hereunder shall cease and terminate. There shall be no refund to Licensee of any Fees paid to MVHS prior to the effective date of the termination, including the License Fee. Upon termination Licensee shall cease to have access to any and all information and records stored by MVHS. Upon termination Licensee shall cease to have the ability to use the Software Product.
    • 4.6 Except as otherwise specifically provided herein, the termination of this Agreement shall not affect the rights, obligations or remedies of either Party which accrued prior to the termination of this Agreement and all such remedies shall survive the termination of this Agreement.
  5. OWNERSHIP
    • 5.1 All rights, title and interest in the Software Product and the Intellectual Property Rights embodied in the Glycocheck System, Software Product, and/or System Hardware, shall at all times reside in MVHS. MVHS retains all rights not expressly granted herein.
    • 5.2 Licensee agrees and acknowledges that MVHS shall be the sole and exclusive owner of any and all right, title and interest in and to Improvements to the GlycoCheck System, whether made or developed by MVHS or by any other entity.
  6. MAINTENANCE AND SUPPORT
    • 6.1 MVHS shall provide to Licensee periodic Updates and/or Upgrades to the Software Product, if and to the extent that said Updates and/or Upgrades become available. MVHS shall, upon discovery of any known problems with the GlycoCheck System, notify Licensee, through Distributor, if any, of said problems and will provide to Licensee any discrepancy reports or technical newsletters when such problems are identified and listing all known “bugs” and their status and, to the extent possible, providing “fixes” and/or work-around procedures for such problems.
  7. REPRESENTATIONS, WARRANTIES, AND DISCLAIMER OF LIABILITY
    • 7.1 Each Party represents and warrants that it has full power and authority to enter into this Agreement and that performance of its obligation hereunder does not conflict with or breach the terms and conditions of any agreement with any third party.
    • 7.2 MVHS warrants that it has the right to convey the license set forth in Section 1 hereof, and that to the best of MVHS’s knowledge, Licensee’s use of the GlycoCheck System in accordance with the terms of this Agreement shall not infringe any third-party rights in copyright, patent, or trade secret.
    • 7.3 MVHS warrants that upon delivery the GlycoCheck System shall be (a) of satisfactory quality, and (b) reasonably fit for its intended purpose.
    • 7.4 MVHS shall provide to Licensee an exclusive limited warranty and service policy for a period of five (5) years from the Effective Date of this Agreement. The terms, conditions and limitations of MVHS’s Warranty and Service Policy can be found here, which may be altered and/or updated from time to time. THE FOREGOING LIMITED WARRANTY IS IN LIEU OF ALL OTHER WARRANTIES AND EXCEPT FOR ANY EXPRESS WARRANTIES STATED HEREIN, MVHS EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED.
    • 7.5 The warranty and service policy referenced in Section 7.4 shall become null and void upon Licensee’s breach of this Agreement, alteration or modification of the GlycoCheck System or any component thereof in any way, or use of any Unauthorized Product in connection with the GlycoCheck System or component thereof.
    • 7.6 EXCEPT AS OTHERWISE PROVIDED HEREIN, MVHS DISCLAIMS ANY AND ALL WARRANTIES, EXPRESS, STATUTORY OR IMPLIED, WITH RESPECT TO THE GLYCOCHECK SYSTEM, DERIVATIVE WORKS, AND DOCUMENTATION, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. MVHS MAKES NO WARRANTY THAT THE GLYCOCHECK SYSTEM WILL MEET LICENSEE’S REQUIREMENTS, BE ERROR FREE, OR OPERATE WITHOUT INTERRUPTION.
    • 7.7 THE PARTIES AGREE THAT MVHS, ANY OF ITS AFFILIATED PERSON/ENTITY OR THIRD PARTY VENDORS SHALL NOT BE LIABLE TO LICENSEE (OR ANY PERSON CLAIMING RIGHTS DERIVED FROM THE LICENSEE’S RIGHTS), EXCEPT AS OTHERWISE PROVIDE HEREIN, FOR ANY DIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES OF ANY NATURE OR KIND WHATSOEVER, INCLUDING, BUT NOT LIMITED TO, LOST REVENUES OR PROFITS, LOSS OF BUSINESS OR OTHER ECONOMIC LOSS, LOSS OF DATA, PERSONAL INJURY, OR PROPERTY DAMAGE IN CONNECTION WITH OR ARISING OUT OF THE USE OF THE GLYCOCHECK SYSTEM AND DERIVATIVE WORKS, IRRESPECTIVE OF WHETHER MVHS HAS ADVANCE NOTICE OF THE POSSIBILITY OF SUCH DAMAGES.
    • 7.8 If the foregoing disclaimers and waivers of liability shall be deemed invalid or ineffective, MVHS, its subsidiaries and affiliates, and any related persons or entities shall not be liable in any and all events beyond the amount of one thousand dollars ($1,000). If the foregoing limitation is held unenforceable, then the Parties agree that MVHS, its subsidiaries, affiliates and any related persons or entities, shall not be liable in any and all events beyond the cumulative total of all fees and compensation paid by Licensee to MVHS under this Agreement (including the License Fee referenced in Section 3.1). Both Parties agree and understand that the pricing for the GlycoCheck System reasonably reflects the allocation of risk and the limitations of the liability set forth in this section.
  8. TRANSFER/ASSIGNABILITY
    • 8.1 This Agreement may not be assigned or transferred by Licensee to any other entity or person. Any attempted assignment in violation hereof shall be void.
    • 8.2 MVHS may freely assign this Agreement at any time to any subsidiary, parent or other affiliate or to any other party in connection with the sale, merger or other business combination involving all or substantially all of that party’s assets of the line of business to which this Agreement pertains.
  9. GENERAL PROVISIONS
    • 9.1 Relationship of the Parties. This Agreement shall not constitute the designation of either Party as the representative or agent of the other, nor shall either Party by this Agreement have the right or authority to make any promise, guarantee, warranty, or representation, or to assume, create, or incur liability or other obligation of any kind, express or implied, against, or in the name of, or on the behalf of, the other Party.
    • 9.2 No Waiver. The failure of any Party to enforce any of its rights hereunder, or at law, shall not be deemed a waiver or a continuing waiver of any of its rights or remedies against the other Party, unless such waiver is in writing and signed by the aggrieved Party.
    • 9.3 Notice. Any official notice to MVHS, as required by this Agreement, shall be sent via email to the address support@microvascular.com. Any official notice to Licensee, as required by this Agreement, shall be sent via email to the contact person and email address registered on Licensee’s MVHS account. Each of the Parties shall be responsible for notifying the other of any changes to the respective Party’s contact information.
    • 9.4 Attorney Fees. In any suit, proceeding or action to enforce any term, condition or covenant of this Agreement or to procure an adjudication or determination of the rights of the Parties, the prevailing Party shall be entitled to recover from the other Party, in addition to any award of costs or disbursements provided by statute, reasonable sums as attorney fees and costs and expenses in connection with such suit, proceeding or action, including appeal, which sums shall be included in any judgment or decree entered therein.
    • 9.5 Injunctive Relief. Notwithstanding the foregoing, it is agreed that any breach of this Agreement by Licensee making any unauthorized use of the GlycoCheck System or engaging in any other conduct which could impair MVHS’s Intellectual Property Rights in the GlycoCheck System will cause immediate and irreparable harm to MVHS. In the event of any such breach by licensee, MVHS shall be entitled to immediate and interim injunctive relief from any court of competent jurisdiction to restrain such unauthorized use or conduct, and to other injunctive relief as may be necessary to protect MVHS’s Intellectual Property Rights.
    • 9.6 Severability. If any one or more provisions of this Agreement shall be found to be illegal, invalid or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and in lieu of such illegal, invalid or unenforceable provision, there shall be added automatically as a part of this Agreement a legal, valid and enforceable provision of similar terms to the extent legally possible.
    • 9.7 Headings. The paragraph headings used herein are for convenience and shall not be deemed to modify or construe the provisions hereof.
    • 9.8 Counterparts. This Agreement may be executed in one or more counterpart copies, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument.
    • 9.9 Force Majeure. Neither Party shall be liable to the other Party for any delay or failure to perform any other services nor did obligations set forth in this Agreement due to cause beyond its reasonable control. Performance times shall be considered extended for a period of time equivalent to the time lost because of such delays.
  10. DEFINITIONS
    • 10.1 “Authorized Users” means those persons who are employed by or affiliated with Licensee who have access to use the GlycoCheck System or to report information to patients concerning such patient’s Glycocalyx layer and/or microvascular function obtained by the Glycocheck System.
    • 10.2 “System Hardware” means the (1) personal computer on which is loaded the Software Product, and (2) the CapiVision Video Microscope Camera, which are provided to Licensee as part of the GlycoCheck System pursuant to the terms and conditions of this Agreement.
    • 10.3 “Documentation” means all user manuals, reference guides, tutorials, videos, brochures, installation manuals, specifications, release notes, error message manuals or other documentation in any media provided by MVHS pertaining to the installation, use, data flows, features or performance of the Software Product.
    • 10.4 “GlycoCheck System” means the combination of the System Hardware and the Software Product, collectively.
    • 10.5 “Improvements” means and includes any improvements, modifications, or amendments to the Software Product, whether made by MVHS or any other party, or their respective employees, agents, or other representatives.
    • 10.6 “Intellectual Property Rights” means patent, application for patent and rights to patent (whether applied for or not), copyrights (whether registered or not), trademarks (whether registered or not), trade secrets, inventions, know-how, moral rights, ideas, processes, techniques, data, confidential information and all other proprietary rights that are embodied in any form of media.
    • 10.7 “Software Product” means the computer software program (in object code form and/or Source Code form), and forming part of the GlycoCheck System, and all associated procedural code, and all components thereof, including all Documentation, Updates, Upgrades, and all other software and documentation provided by MVHS to Licensee and/or through Distributor, if any, and all intellectual property rights therein.
    • 10.8 “Source Code” means (i) the human-readable code making up the Software Product and all other software required for a reasonably skilled programmer to compile the machine-executable software code for such Software Product, including all required tools that are not commercially available on an off-the-shelf basis, and (ii) all related design charts, data flows and other documentation related to the Software Product needed to maintain and understand the code of the Software Product and all other similar documentation that would assist a programmer in the maintenance of the Software Product.
    • 10.9 “Updates” means any and all fixes, patches, and corrections to, the Software Product or Documentation made independently by MVHS and made generally available by Licensor to Licensee.
    • 10.10 “Upgrades” means any enhancements, improvements, new releases, new versions and any material changes to the Software Product or Documentation made independently by MVHS and generally offered by MVHS.
    • 10.11 “Unauthorized Product” means any product used in connection with the GlycoCheck System or a component thereof that is not provided by MVHS and/or through Distributor, if any, to Licensee, including, but not limited to, (i) consumables, such as video microscope camera lens covers or tips, (ii) replacement laptop components, such as batteries, and (iii) software updates, fixes, or upgrades, but shall not include customary laptop accessories, such as a keyboard or mouse.
    • 10.12 “Distributor” means a company or individual authorized by MVHS to sell or lease the Glycocheck System.
    • 10.13 “You” or “Your” means the Licensee as defined above.